Bin Chen

TL;DR: These recommendations are intended for laboratories that perform molecular genetic testing for heritable diseases and conditions and for medical and public health professionals who evaluate laboratory practices and policies to improve the quality of molecular genetic laboratory services.

TL;DR: Improving the availability of appropriate QC materials is of critical importance for assuring the quality of genetic testing, enhancing performance evaluation and PT/EQA programs, and facilitating new test development.

TL;DR: In this paper, the authors present a review of clinical laboratory biosafety in the 2014 Ebola outbreak, focusing on the areas of risk assessment and management, automated and manual laboratory disciplines, specimen collection, processing, and storage; test utilization; equipment and instrumentation safety; disinfection practices; personal protective equipment; waste management; laboratory personnel training and competency assessment; accreditation processes; and ethical guidance.

TL;DR: Good laboratory practices for molecular genetic testing for heritable diseases and conditions as discussed by the authors were developed based on recommendations from the Clinical Laboratory Improvement Advisory Committee, with additional input from the secretary's Advisory Committee on Genetics, Health, and Society; the Secretary's Advisory committee on Heritable Disorders in Newborns and Children; and representatives of newborn screening laboratories.